Emergent BioSolutions Inc (NYSE:EBS)
| 13.47 Delayed Data As of Jan 27 |  +0.35 / +2.67%Today’s Change | 10.61 Today|||52-Week Range 47.71 | +14.06% Year-to-Date |
Institutional investors purchased a net $936.8 thousand shares of EBS during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 85.42% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Mutual fund holders | 58.62% |
| Other institutional | 26.80% |
| Individual stakeholders | 25.03% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | SSGA FUNDS MANAGEMENT, INC. Bought 1.5 Million shares of Emergent BioSolutions Inc |
| 12/31/2022 | VALUES FIRST ADVISORS, INC. Bought 19.9 Thousand shares of Emergent BioSolutions Inc |
| 12/31/2022 | STATE TEACHERS RETIREMENT SYSTEM... Bought 17.2 Thousand shares of Emergent BioSolutions Inc |
Top 10 Owners of Emergent BioSolutions Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BlackRock Fund Advisors | 14.92% | 7,445,360 | 87,929,702 | -190,189 | -2.49% |
| SSgA Funds Management, Inc. | 11.66% | 5,817,955 | 68,710,049 | +1,501,645 | +34.79% |
| The Vanguard Group, Inc. | 10.23% | 5,103,152 | 60,268,225 | +99,228 | +1.98% |
| Dimensional Fund Advisors LP | 3.85% | 1,922,230 | 22,701,536 | -25,102 | -1.29% |
| D. E. Shaw & Co. LP | 1.99% | 992,213 | 11,718,036 | -73,734 | -6.92% |
| Jacobs Levy Equity Management, In... | 1.94% | 968,506 | 11,438,056 | -117,368 | -10.81% |
| Invesco Capital Management LLC | 1.93% | 964,617 | 11,392,127 | +155,670 | +19.24% |
| Geode Capital Management LLC | 1.68% | 836,420 | 9,878,120 | +4,469 | +0.54% |
| Northern Trust Investments, Inc.(... | 1.67% | 832,644 | 9,833,526 | +241,812 | +40.93% |
| Neuberger Berman Investment Advis... | 1.38% | 686,449 | 8,106,963 | +36,348 | +5.59% |
Top 10 Mutual Funds Holding Emergent BioSolutions Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | 8.18% | 4,079,143 | 48,174,679 | +16,496 | +0.41% |
| iShares Core S&P Small Cap ETF | 6.58% | 3,284,559 | 38,790,642 | -2,496 | -0.08% |
| Vanguard Total Stock Market Index... | 2.71% | 1,352,002 | 15,967,144 | 0 | 0.00% |
| Vanguard Small Cap Index Fund | 2.32% | 1,156,830 | 13,662,162 | -84 | -0.01% |
| iShares Russell 2000 ETF | 2.26% | 1,125,814 | 13,295,863 | -11,773 | -1.03% |
| Invesco Dynamic Pharmaceuticals E... | 1.75% | 870,359 | 10,278,940 | 0 | 0.00% |
| Vanguard Small Cap Value Index Fu... | 1.62% | 809,462 | 9,559,746 | +7,869 | +0.98% |
| iShares S&P Small Cap 600 Value E... | 1.44% | 717,988 | 8,479,438 | -6,294 | -0.87% |
| Vanguard Extended Market Index Fu... | 1.24% | 619,312 | 7,314,075 | +1,338 | +0.22% |
| Invesco Dynamic Biotechnology & G... | 1.14% | 568,161 | 6,709,981 | +7,100 | +1.27% |